Top 1% Biotech Longboard Scores A $2.6 Billion Deal And Skyrockets To A Record
Lundbeck announced Monday it would buy Longboard Pharmaceuticals in a $2.6 billion deal that sent Longboard stock to a record high. The post Top 1% Biotech Longboard Scores A $2.6 Billion Deal And Skyrockets To A Record appeared first on Investor's Business Daily.

Lundbeck announced Monday it would buy Longboard Pharmaceuticals in a $2.6 billion deal that sent Longboard stock to a record high.
The post Top 1% Biotech Longboard Scores A $2.6 Billion Deal And Skyrockets To A Record appeared first on Investor's Business Daily.